combination therapies

0:57:02

Cellular Horizons Day 2 - Combination Therapies for Cancer

0:55:27

Marcello Delitala: Combination therapies and drug resistance in heterogeneous tumoral populations

0:02:47

MHCC Combination Therapies: Selection and Differentiation

0:08:14

Key Trials in mCRC: I/O Combination Therapies

0:04:02

Fall 2023 Conference Coverage: Impact of Combination Therapies for Neuromuscular Disorders

0:15:15

Comparing Combination Therapies with Oncolytic Viruses in a Simple Mathematical Framework

0:05:52

Combination Therapies in Bladder Cancer: Insights and Challenges

0:01:41

Targeting HER2 by Combination Therapies

0:00:48

Therapeutic cancer vaccine combination therapies in pancreatic cancer

0:02:23

The potential impact of combination therapies on the landscape of myelofibrosis treatment

0:00:12

Combination therapies like Anti-wrinkle injections,microneedling an PDLLA - Lenisna and Juvelook

0:01:34

Combination therapies for the treatment of prostate cancer

0:05:30

Using Combination Therapies in Advanced pNETs

0:01:18

Combination therapies involving KRAS G12C inhibitors in lung cancer

0:23:40

New Combination Therapies in the Future

0:03:41

Toxicity Considerations for Multiple Myeloma Combination Therapies

0:05:01

Combination Therapies: What Works Best for Immuno-Oncology?

0:01:17

Dr. Grivas on Promising Combination Therapies in Bladder Cancer

0:02:04

Dr. Chiorean on Combination Therapies for Pancreatic Cancer

0:00:44

Optimizing combination therapies to overcome PARP inhibitor resistance

0:01:42

Novel triple combination therapies for melanoma

0:19:11

Novel Agents and Combination Therapies in Myelofibrosis

0:35:58

ESMO 2021: PARPi data and their role in mono/combination therapies

0:03:36

PARP Combination Therapies in Ovarian Cancer